Manufacture of pharmaceutical preparations
ALGINOR PHARMA INGREDIENTS AS
Operating profit
NOK −317,000
Equity
NOK 9.8m
Incorporated
2021
Share capital
NOK 10.0m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating costs | 317k | |
| Operating profit (EBIT) | −317k | |
| Net financial items | 89k | |
| Profit for the year | −228k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 33.0m | |
| of which current assets | 6.3m | |
| Equity | 9.8m | |
| Total liabilities | 23.3m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.